Skip to main content
Event ended - Missed this event? Check out these other events happening soon Looking for the details about the previous event, just scroll down.

Loading...

 
 
  • Are you an organiser?

    Maximise your event's success with Billetto - the ticketing platform that helps you sell more tickets, promote with ease and save time.

  • A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19

    Event ended

    A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19

    From Free

    Online Event

    Date

    Oct 25 2022 11:00 - 13:00
    Billetto Peace of Mind
    Book with confidence: Billetto guarantees refunds for cancelled events, ensuring your peace of mind. Learn more
    Payment methods accepted:

    Description

    SARS-CoV-2 is a highly contagious and pathogenic coronavirus that causes a pandemic of the acute respiratory disease known as COVID-19 and threatens human health and public safety. Research has shown that neutralizing antibodies to SARS-CoV-2 is one of the most effective treatments for COVID-19. Compared with traditional antibodies, single-domain antibodies (sdAbs) have small molecular weight and high hydrophilicity, which can bind epitopes that traditional antibodies cannot. At the same time, single-domain antibodies have higher tissue penetration and stability, and are easier to be modified, optimized, and humanized. Meanwhile, they are suitable for large-scale industrial production. Due to the above characteristics, single-domain antibodies against SARS-CoV-2 will be of great significance for the treatment of COVID-19.

    Creative Biolabs has invited Dr. James Naismith to walk us through the development of his novel SARS-CoV-2 neutralizing sdAbs and how his team has found a candidate demonstrating promising therapeutic efficacy in a hamster model of COVID-19.

    The following key points will be discussed in this webinar:

    • SdAbs which bind to SARS-CoV-2 have been identified from both naive library and llama challenge.
    • SdAbs target two broad epitopes, highlighting the role of E484 in first-generation agents.
    • It is possible to make two formulations that showed potency in a hamster therapeutic model.


    Organiser

    FAQ

    • I have not received my A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19 ticket via email. What should I do?

      The first thing to do is check your spam/junk filters and inboxes. Your A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19 tickets were sent as an attachment and can be thought of as spam by some email services. Alternatively, you can always find your A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19 tickets in your Billetto account that you can access in the browsers or the dedicated Billetto app. For more help with this, read here.

    • I wish to cancel my A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19 ticket and receive a refund. What should I do?

      The approval of refunds is entirely at the event organiser’s discretion, and you should get in contact with the event organiser to discuss what options are available to you. To get in touch with the event organiser, simply reply to your order confirmation email or use the "Contact organiser" form on the organiser's profile. For more help with this, read here.

    • I have registered on the A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19 waiting list, what happens now?

      If more tickets become available you will be notified (by email) amongst others who have joined the list. Purchasing is on a first-come first-serve basis. For more information, read here.

    • Where do I find a link to an online event?

      Check your order confirmation page or order confirmation email. Usually, the organiser of the event provides the details in the order confirmation email or they might send you a follow-up email with a link to their online event. You might also want to read the event description on Billetto where an event organiser should describe how to join the A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19 event online. For more information on this, read here.

    • What is refund protection and why would I need it?

      Refund Protection provides you with the assurance that if unforeseen and unavoidable circumstances interfere with your ability to attend an event you can claim a refund. For more information on this, read here.

    Event ended

    A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19

    Discover more